The Klotho proteins in health and disease

[1]  K. Rye,et al.  Fibroblast growth factor 21 in chronic kidney disease. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[2]  M. Kuro-o.  Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications? , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  M. Kuro-o,et al.  The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio, Deemed the Nephron Index, Is a Useful Clinical Index for Early Stage Chronic Kidney Disease in Patients with Type 2 Diabetes: An Observational Pilot Study , 2018, International journal of nephrology.

[4]  S. Anton,et al.  Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis , 2018, Ageing Research Reviews.

[5]  L. Gesualdo,et al.  Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease , 2018, Pharmacological research.

[6]  James Woodcock,et al.  Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis , 2018, European Journal of Epidemiology.

[7]  M. Kuro-o,et al.  Daily variability in serum levels of calciprotein particles and their association with mineral metabolism parameters: A cross‐sectional pilot study , 2018, Nephrology.

[8]  K. Kotani,et al.  Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease , 2018, Scientific Reports.

[9]  M. Mohammadi,et al.  αKlotho is a Non-Enzymatic Molecular Scaffold for FGF23 Hormone Signaling , 2018, Nature.

[10]  M. Lanaspa,et al.  Novel treatment strategies for chronic kidney disease: insights from the animal kingdom , 2018, Nature Reviews Nephrology.

[11]  M. Kuro-o.  Ageing-related receptors resolved. , 2018 .

[12]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[13]  B. Isaksson,et al.  Circulating Fibroblast Growth Factor 19 in Portal and Systemic Blood. , 2017, Journal of clinical and experimental hepatology.

[14]  D. Tousoulis,et al.  The Role of Oxidative Stress , 2018 .

[15]  E. Pardon,et al.  Structures of β-klotho reveal a ‘zip code’-like mechanism for endocrine FGF signalling , 2018, Nature.

[16]  S. Kliewer,et al.  FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia. , 2017, Cell metabolism.

[17]  P. Leung,et al.  Fibroblast growth factor 21: a regulator of metabolic disease and health span. , 2017, American journal of physiology. Endocrinology and metabolism.

[18]  Glenville Jones,et al.  A kidney-specific genetic control module in mice governs endocrine regulation of the cytochrome P450 gene Cyp27b1 essential for vitamin D3 activation , 2017, The Journal of Biological Chemistry.

[19]  Jennifer J. Kohler,et al.  Modeled structural basis for the recognition of α2–3‐sialyllactose by soluble Klotho , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  M. Kuro-o,et al.  FGF23-αKlotho as a paradigm for a kidney-bone network. , 2017, Bone.

[21]  Y. Asano,et al.  Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease , 2017, PloS one.

[22]  J. Hillebrands,et al.  The role of the anti-ageing protein Klotho in vascular physiology and pathophysiology , 2017, Ageing Research Reviews.

[23]  Masaya Takahashi,et al.  Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy. , 2017, Kidney international.

[24]  K. White,et al.  Chronic Hyperphosphatemia and Vascular Calcification Are Reduced by Stable Delivery of Soluble Klotho. , 2017, Journal of the American Society of Nephrology : JASN.

[25]  F. Bäckhed,et al.  Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling , 2017, Digestive Diseases.

[26]  J. Xie,et al.  Klotho May Ameliorate Proteinuria by Targeting TRPC6 Channels in Podocytes. , 2017, Journal of the American Society of Nephrology : JASN.

[27]  A. Rule,et al.  The Substantial Loss of Nephrons in Healthy Human Kidneys with Aging. , 2017, Journal of the American Society of Nephrology : JASN.

[28]  Jodie L Babitt,et al.  Ironing out the cross talk between FGF23 and inflammation. , 2017, American journal of physiology. Renal physiology.

[29]  M. Kuro-o,et al.  The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio Is a Useful Marker of Atherosclerosis in Early-Stage Chronic Kidney Disease , 2016, PloS one.

[30]  B. Lanske,et al.  In vivo evidence for a limited role of proximal tubular Klotho in renal phosphate handling. , 2016, Kidney international.

[31]  S. de Seigneux,et al.  Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition. , 2016, Pharmacological research.

[32]  F. Lang,et al.  Up-regulation of FGF23 release by aldosterone. , 2016, Biochemical and biophysical research communications.

[33]  S. Sidhu,et al.  Renal Production, Uptake, and Handling of Circulating αKlotho. , 2016, Journal of the American Society of Nephrology : JASN.

[34]  Han Jun Cho,et al.  Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. , 2015, Journal of the American Society of Nephrology : JASN.

[35]  R. Hinton,et al.  COX2 Inhibition Reduces Aortic Valve Calcification In Vivo , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[36]  J. Goldstein,et al.  A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins , 2015, Cell.

[37]  E. Schleicher,et al.  NH4Cl Treatment Prevents Tissue Calcification in Klotho Deficiency. , 2015, Journal of the American Society of Nephrology : JASN.

[38]  M. Mohammadi,et al.  The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  S. Kliewer,et al.  Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21 , 2015, Trends in Endocrinology & Metabolism.

[40]  V. Morwitz.  Insights from the Animal Kingdom , 2014 .

[41]  M. Razzaque,et al.  Calpain 1 inhibitor BDA-410 ameliorates α-klotho-deficiency phenotypes resembling human aging-related syndromes , 2014, Scientific Reports.

[42]  Laura C. Greaves,et al.  Chronic inflammation induces telomere dysfunction and accelerates ageing in mice , 2014, Nature Communications.

[43]  J. Beyene,et al.  Association between depression and mortality in patients receiving long-term dialysis: a systematic review and meta-analysis. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[44]  B. Lanske,et al.  FGF23 promotes renal calcium reabsorption through the TRPV5 channel , 2014, The EMBO journal.

[45]  B. Lanske,et al.  FGF23 regulates renal sodium handling and blood pressure , 2012, EMBO molecular medicine.

[46]  B. Lanske,et al.  Parathyroid-Specific Deletion of Klotho Unravels a Novel Calcineurin-Dependent FGF23 Signaling Pathway That Regulates PTH Secretion , 2013, PLoS genetics.

[47]  Edward R. Smith,et al.  Fetuin‐A‐containing calciprotein particle levels can be reduced by dialysis, sodium thiosulphate and plasma exchange. Potential therapeutic implications for calciphylaxis? , 2013, Nephrology.

[48]  J. Axelsson,et al.  Impaired postprandial fibroblast growth factor (FGF)-19 response in patients with stage 5 chronic kidney diseases is ameliorated following antioxidative therapy. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[49]  H. Fu,et al.  The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. , 2013, Cell metabolism.

[50]  C. McClung,et al.  How Might Circadian Rhythms Control Mood? Let Me Count the Ways... , 2013, Biological Psychiatry.

[51]  S. Kliewer,et al.  FGF21 regulates metabolism and circadian behavior by acting on the nervous system , 2013, Nature Medicine.

[52]  P. Stenvinkel,et al.  Chronic kidney disease: a clinical model of premature aging. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[53]  R. Townsend,et al.  Ambulatory Blood Pressure in Chronic Kidney Disease , 2013, Current Hypertension Reports.

[54]  Edward R. Smith,et al.  Fetuin-A-Containing Calciprotein Particles Reduce Mineral Stress in the Macrophage , 2013, PloS one.

[55]  M. Mohammadi,et al.  Arterial Klotho Expression and FGF23 Effects on Vascular Calcification and Function , 2013, PloS one.

[56]  M. Shlipak,et al.  Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes. , 2013, Journal of the American Society of Nephrology : JASN.

[57]  M. Kuro-o,et al.  Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. , 2013, Annual review of physiology.

[58]  E. Brown,et al.  Interactions between calcium and phosphorus in the regulation of the production of fibroblast growth factor 23 in vivo. , 2013, American journal of physiology. Endocrinology and metabolism.

[59]  R. Gimeno,et al.  The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue. , 2013, Molecular metabolism.

[60]  E. Farrow,et al.  Circulating αKlotho influences phosphate handling by controlling FGF23 production. , 2012, The Journal of clinical investigation.

[61]  S. Kliewer,et al.  The starvation hormone, fibroblast growth factor-21, extends lifespan in mice , 2012, eLife.

[62]  H. Olauson,et al.  Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism. , 2012, Journal of the American Society of Nephrology : JASN.

[63]  B. Lanske,et al.  FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2–SGK1 signaling pathway , 2012, Bone.

[64]  Y. Furukawa,et al.  Promoter methylation confers kidney‐specific expression of the Klotho gene , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[65]  M. Kuro-o.  Klotho in health and disease , 2012, Current opinion in nephrology and hypertension.

[66]  J. Muñoz-Castañeda,et al.  Calcium deficiency reduces circulating levels of FGF23. , 2012, Journal of the American Society of Nephrology : JASN.

[67]  M. Kuro-o,et al.  Klotho gene delivery suppresses Nox2 expression and attenuates oxidative stress in rat aortic smooth muscle cells via the cAMP‐PKA pathway , 2012, Aging cell.

[68]  A. Garg,et al.  Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[69]  Edward R. Smith,et al.  Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[70]  S. Kliewer,et al.  Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ , 2012, Proceedings of the National Academy of Sciences.

[71]  Stacey A. Jones.  Physiology of FGF15/19. , 2012, Advances in experimental medicine and biology.

[72]  A. Go,et al.  FGF23 induces left ventricular hypertrophy. , 2011, The Journal of clinical investigation.

[73]  Ryan E. Forster,et al.  Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells. , 2011, Biochemical and biophysical research communications.

[74]  E. Farrow,et al.  Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. , 2011, Bone.

[75]  G. Navis,et al.  Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.

[76]  B. Lanske,et al.  FGF‐23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[77]  Lei Wang,et al.  Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice. , 2011, The Journal of clinical investigation.

[78]  B. Spiegelman,et al.  Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo. , 2011, Endocrinology.

[79]  X. Ao,et al.  Fosinopril and Losartan Regulate Klotho Gene and Nicotinamide Adenine Dinucleotide Phosphate Oxidase Expression in Kidneys of Spontaneously Hypertensive Rats , 2011, Kidney and Blood Pressure Research.

[80]  Huiliang Xie,et al.  Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. , 2011, Kidney international.

[81]  S. Kliewer,et al.  FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis , 2011, Science.

[82]  Y. Tintut,et al.  Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. , 2011, Kidney international.

[83]  N. Itoh,et al.  Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. , 2011, Journal of biochemistry.

[84]  O. Togao,et al.  Klotho Inhibits Transforming Growth Factor-β1 (TGF-β1) Signaling and Suppresses Renal Fibrosis and Cancer Metastasis in Mice* , 2011, The Journal of Biological Chemistry.

[85]  M. Kuro-o.  Phosphate and Klotho. , 2011, Kidney international.

[86]  M. Kuro-o,et al.  Klotho deficiency causes vascular calcification in chronic kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.

[87]  M. Kuro-o,et al.  Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. , 2010, Kidney international.

[88]  T. Larsson,et al.  Fibroblast growth factor-23 and mineral metabolism after unilateral nephrectomy. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[89]  T. Shimada,et al.  Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. , 2010, Kidney international.

[90]  Takayuki Hamano,et al.  Fetuin-mineral complex reflects extraosseous calcification stress in CKD. , 2010, Journal of the American Society of Nephrology : JASN.

[91]  S. Kliewer,et al.  Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. , 2010, Molecular endocrinology.

[92]  J. Silver,et al.  PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. , 2010, American journal of physiology. Renal physiology.

[93]  K. Rosenblatt,et al.  Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[94]  M. Econs,et al.  Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects. , 2010, Biochemical and biophysical research communications.

[95]  J. Bacchetta,et al.  The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease. , 2010, The Journal of clinical endocrinology and metabolism.

[96]  M. Kuro-o.  A potential link between phosphate and aging—Lessons from Klotho-deficient mice , 2010, Mechanisms of Ageing and Development.

[97]  C. Kenyon.  The genetics of ageing , 2010, Nature.

[98]  T. Lawrence.  The nuclear factor NF-kappaB pathway in inflammation. , 2009, Cold Spring Harbor perspectives in biology.

[99]  M. Razzaque,et al.  In Vivo Genetic Evidence for Suppressing Vascular and Soft-Tissue Calcification Through the Reduction of Serum Phosphate Levels, Even in the Presence of High Serum Calcium and 1,25-Dihydroxyvitamin D Levels , 2009, Circulation. Cardiovascular genetics.

[100]  Tracy Dew,et al.  A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[101]  P. Saftig,et al.  Klotho is a substrate for α‐, β‐ and γ‐secretase , 2009 .

[102]  Y. Nakaya,et al.  Dietary phosphorus acutely impairs endothelial function. , 2009, Journal of the American Society of Nephrology : JASN.

[103]  S. Cha,et al.  Regulation of Renal Outer Medullary Potassium Channel and Renal K+ Excretion by Klotho , 2009, Molecular Pharmacology.

[104]  S. Kliewer,et al.  FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response , 2009, Proceedings of the National Academy of Sciences.

[105]  E. Farrow,et al.  Initial FGF23-mediated signaling occurs in the distal convoluted tubule. , 2009, Journal of the American Society of Nephrology : JASN.

[106]  R. Villa-Bellosta,et al.  Phosphonoformic Acid Prevents Vascular Smooth Muscle Cell Calcification by Inhibiting Calcium-Phosphate Deposition , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[107]  David J. Webb,et al.  Emerging Concepts , 2009 .

[108]  M. Kuro-o,et al.  Endocrine fibroblast growth factors as regulators of metabolic homeostasis , 2009, Biofactors.

[109]  J. Hoeijmakers,et al.  Correction: Impaired Genome Maintenance Suppresses the Growth Hormone–Insulin-Like Growth Factor 1 Axis in Mice with Cockayne Syndrome , 2008, PLoS Biology.

[110]  Jing Wu,et al.  Klotho is a target gene of PPAR-gamma. , 2008, Kidney international.

[111]  M. Kuro-o.  Endocrine FGFs and Klothos: emerging concepts , 2008, Trends in Endocrinology & Metabolism.

[112]  T. Ohtake,et al.  Associations of Renal Vascular Resistance With Albuminuria and Other Macroangiopathy in Type 2 Diabetic Patients , 2008, Diabetes Care.

[113]  Alexandra E. Ewence,et al.  Calcium Phosphate Crystals Induce Cell Death in Human Vascular Smooth Muscle Cells: A Potential Mechanism in Atherosclerotic Plaque Destabilization , 2008, Circulation research.

[114]  T. Breit,et al.  Delayed and Accelerated Aging Share Common Longevity Assurance Mechanisms , 2008, PLoS genetics.

[115]  K. Rosenblatt,et al.  Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1 , 2008, Proceedings of the National Academy of Sciences.

[116]  S. Kliewer,et al.  Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. , 2008, Cell metabolism.

[117]  W. Wittkowski,et al.  Increased inorganic phosphate induces human endothelial cell apoptosis in vitro. , 2008, American journal of physiology. Renal physiology.

[118]  C. Brownstein,et al.  A translocation causing increased α-Klotho level results in hypophosphatemic rickets and hyperparathyroidism , 2008, Proceedings of the National Academy of Sciences.

[119]  R. Carano,et al.  Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models , 2008, Oncogene.

[120]  C. Ohlsson,et al.  Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[121]  S. Leeman,et al.  Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17 , 2007, Proceedings of the National Academy of Sciences.

[122]  M. Mohammadi,et al.  The parathyroid is a target organ for FGF23 in rats. , 2007, The Journal of clinical investigation.

[123]  W. Pan,et al.  The fasting polypeptide FGF21 can enter brain from blood , 2007, Peptides.

[124]  J. Coresh,et al.  Prevalence of chronic kidney disease in the United States. , 2007, JAMA.

[125]  S. Kliewer,et al.  Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21* , 2007, Journal of Biological Chemistry.

[126]  Michael D. Schneider,et al.  TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. , 2007, The Journal of clinical investigation.

[127]  K. White,et al.  A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. , 2007, Journal of musculoskeletal & neuronal interactions.

[128]  C. Kuo,et al.  Augmented Wnt Signaling in a Mammalian Model of Accelerated Aging , 2007, Science.

[129]  Jason R. Stubbs,et al.  Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. , 2007, Journal of the American Society of Nephrology : JASN.

[130]  Shinzo Tanaka,et al.  α-Klotho as a Regulator of Calcium Homeostasis , 2007, Science.

[131]  J. Flier,et al.  Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. , 2007, Cell metabolism.

[132]  S. Kliewer,et al.  Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. , 2007, Cell metabolism.

[133]  K. Rosenblatt,et al.  βKlotho is required for metabolic activity of fibroblast growth factor 21 , 2007, Proceedings of the National Academy of Sciences.

[134]  W. Jahnen-Dechent,et al.  Structural dynamics of a colloidal protein-mineral complex bestowing on calcium phosphate a high solubility in biological fluids , 2007, Biointerphases.

[135]  S. Kliewer,et al.  Molecular Insights into the Klotho-Dependent, Endocrine Mode of Action of Fibroblast Growth Factor 19 Subfamily Members , 2007, Molecular and Cellular Biology.

[136]  M. Haussler,et al.  1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[137]  N. Tomita,et al.  Amelioration of progressive renal injury by genetic manipulation of Klotho gene , 2007, Proceedings of the National Academy of Sciences.

[138]  Y. Nabeshima,et al.  Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice. , 2007, American journal of physiology. Renal physiology.

[139]  J. Hoeijmakers,et al.  Impaired Genome Maintenance Suppresses the Growth Hormone–Insulin-Like Growth Factor 1 Axis in Mice with Cockayne Syndrome , 2006, PLoS biology.

[140]  J. Hoeijmakers,et al.  A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis , 2006, Nature.

[141]  K. Okawa,et al.  Klotho converts canonical FGF receptor into a specific receptor for FGF23 , 2006, Nature.

[142]  P. Carmeliet,et al.  Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. , 2006, The Journal of clinical investigation.

[143]  L. Bonewald,et al.  Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism , 2006, Nature Genetics.

[144]  Daniel L. Koller,et al.  The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis. , 2006, The Journal of clinical endocrinology and metabolism.

[145]  T. Strom,et al.  Polypeptide GalNAc-transferase T3 and Familial Tumoral Calcinosis , 2006, Journal of Biological Chemistry.

[146]  Xi Jiang,et al.  Pathogenic role of Fgf23 in Hyp mice. , 2006, American journal of physiology. Endocrinology and metabolism.

[147]  L. Cebotaru,et al.  WNK4 kinase regulates surface expression of the human sodium chloride cotransporter in mammalian cells. , 2006, Kidney international.

[148]  Jason R. Stubbs,et al.  Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. , 2006, Journal of the American Society of Nephrology : JASN.

[149]  J. van Loon.  Network , 2006 .

[150]  K. Rosenblatt,et al.  Regulation of Fibroblast Growth Factor-23 Signaling by Klotho* , 2006, Journal of Biological Chemistry.

[151]  J. Marth,et al.  Dietary and Genetic Control of Glucose Transporter 2 Glycosylation Promotes Insulin Secretion in Suppressing Diabetes , 2005, Cell.

[152]  D. Clapham,et al.  TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function , 2005, Nature Genetics.

[153]  M. Mitobe,et al.  Klotho reduces apoptosis in experimental ischaemic acute renal failure. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[154]  K. White,et al.  Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. , 2005, Endocrinology.

[155]  J. Hoenderop,et al.  The ß-Glucuronidase Klotho Hydrolyzes and Activates the TRPV5 Channel , 2005, Science.

[156]  S. Kliewer,et al.  Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. , 2005, Cell metabolism.

[157]  Animesh Nandi,et al.  Suppression of Aging in Mice by the Hormone Klotho , 2005, Science.

[158]  S. Kato,et al.  Role of the vitamin D receptor in FGF23 action on phosphate metabolism. , 2005, The Biochemical journal.

[159]  Y. Nabeshima,et al.  Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho. , 2005, The Journal of clinical investigation.

[160]  M. Pericak-Vance,et al.  A Mutation in the TRPC6 Cation Channel Causes Familial Focal Segmental Glomerulosclerosis , 2005, Science.

[161]  J. Gromada,et al.  FGF-21 as a novel metabolic regulator. , 2005, The Journal of clinical investigation.

[162]  K. White,et al.  FGF23 and disorders of phosphate homeostasis. , 2005, Cytokine & growth factor reviews.

[163]  Shaun K Olsen,et al.  Structural basis for fibroblast growth factor receptor activation. , 2005, Cytokine & growth factor reviews.

[164]  H. Dyson,et al.  Intrinsically unstructured proteins and their functions , 2005, Nature Reviews Molecular Cell Biology.

[165]  Robert J. Linhardt,et al.  Analysis of Mutations in Fibroblast Growth Factor (FGF) and a Pathogenic Mutation in FGF Receptor (FGFR) Provides Direct Evidence for the Symmetric Two-End Model for FGFR Dimerization , 2005, Molecular and Cellular Biology.

[166]  R. Unger.  Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine. , 2005, Biochimie.

[167]  L. Schurgers,et al.  Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. , 2004, Journal of the American Society of Nephrology : JASN.

[168]  J. Dennis,et al.  Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis , 2004, Science.

[169]  R. Soriano,et al.  Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. , 2004, Endocrinology.

[170]  K. Nozaki,et al.  Secreted Klotho protein in sera and CSF: implication for post‐translational cleavage in release of Klotho protein from cell membrane , 2004, FEBS letters.

[171]  Y. Takeuchi,et al.  Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. , 2004, The Journal of clinical investigation.

[172]  H. Murer,et al.  The sodium phosphate cotransporter family SLC34 , 2004, Pflügers Archiv.

[173]  T. Blundell,et al.  The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity. , 2004, Biochemistry.

[174]  Y. Takeuchi,et al.  FGF‐23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[175]  K. Fukuda,et al.  Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. , 2003, Molecular endocrinology.

[176]  T. Renné,et al.  Structural Basis of Calcification Inhibition by α2-HS Glycoprotein/Fetuin-A , 2003, The Journal of Biological Chemistry.

[177]  T. Nabeshima,et al.  Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[178]  M. Kurabayashi,et al.  Expression of Klotho protein in the inner ear , 2002, Hearing Research.

[179]  Y. Hayashizaki,et al.  Identification of a novel mouse membrane-bound family 1 glycosidase-like protein, which carries an atypical active site structure. , 2002, Biochimica et biophysica acta.

[180]  G. Frantz,et al.  A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. , 2002, The American journal of pathology.

[181]  D. French,et al.  Printed in U.S.A. Copyright © 2002 by The Endocrine Society Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity , 2022 .

[182]  I. Mian,et al.  Association of human aging with a functional variant of klotho , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[183]  Y. Nabeshima,et al.  The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc. , 2001, The Journal of nutrition.

[184]  S. Takeda,et al.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[185]  A. Tamori,et al.  Severely reduced production of klotho in human chronic renal failure kidney. , 2001, Biochemical and biophysical research communications.

[186]  T. Meitinger,et al.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 , 2000, Nature Genetics.

[187]  Y. Nabeshima,et al.  Molecular cloning and expression analyses of mouse βklotho, which encodes a novel Klotho family protein , 2000, Mechanisms of Development.

[188]  J. Schlessinger,et al.  Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. , 2000, Molecular cell.

[189]  C. Deng,et al.  Elevated Cholesterol Metabolism and Bile Acid Synthesis in Mice Lacking Membrane Tyrosine Kinase Receptor FGFR4* , 2000, The Journal of Biological Chemistry.

[190]  R. Nagai,et al.  Disruption of the klotho gene causes pulmonary emphysema in mice. Defect in maintenance of pulmonary integrity during postnatal life. , 2000, American journal of respiratory cell and molecular biology.

[191]  H. Dyson,et al.  Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. , 1999, Journal of molecular biology.

[192]  M. Kuro-o,et al.  Independent impairment of osteoblast and osteoclast differentiation in klotho mouse exhibiting low-turnover osteopenia. , 1999, The Journal of clinical investigation.

[193]  O. Meijer,et al.  Epithelial sodium channel regulated by aldosterone-induced protein sgk. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[194]  Jeremy Fairbank,et al.  Historical Perspective , 1987, Blood Traces.

[195]  T. Suga,et al.  Molecular cloning of rat klotho cDNA: markedly decreased expression of klotho by acute inflammatory stress. , 1998, Biochemical and biophysical research communications.

[196]  R. Nagai,et al.  Klotho protein protects against endothelial dysfunction. , 1998, Biochemical and biophysical research communications.

[197]  I S Mian,et al.  Sequence, structural, functional, and phylogenetic analyses of three glycosidase families. , 1998, Blood cells, molecules & diseases.

[198]  M. Kuro-o,et al.  Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein 1 , 1998, FEBS letters.

[199]  R. Nagai,et al.  Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. , 1998, Biochemical and biophysical research communications.

[200]  Tadashi Kaname,et al.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing , 1997, Nature.

[201]  A. Poustka,et al.  A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets , 1995, Nature Genetics.

[202]  E. Brown,et al.  Cloning and characterization of an extracellular Ca(2+)-sensing receptor from parathyroid and kidney: new insights into the physiology and pathophysiology of calcium metabolism. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[203]  J. Puschett,et al.  Inhibition by volume expansion of phosphate uptake by the renal proximal tubule brush border membrane. , 1989, Biochemical pharmacology.

[204]  J. Puschett,et al.  Inhibitory effects of volume expansion performed in vivo on transport in the isolated rabbit proximal tubule perfused in vitro. , 1988, The Journal of clinical investigation.

[205]  A. Alfrey,et al.  Renal toxicity of phosphate in rats. , 1980, Kidney international.

[206]  H. Aynedjian,et al.  A micropuncture study of renal phosphate transport in rats with chronic renal failure and secondary hyperparathyroidism. , 1978, The Journal of clinical investigation.

[207]  N. Kretchmer.  Lactose and lactase--a historical perspective. , 1971, Gastroenterology.

[208]  E. Mackay,et al.  RENAL DAMAGE FOLLOWING THE INGESTION OF A DIET CONTAINING AN EXCESS OF INORGANIC PHOSPHATE , 1935, The Journal of experimental medicine.